Clinical trial
A Case-Control Observational Study of Peripheral Blood-Derived iPSC Models to Investigate Oligodendrocyte Lineage Development in Children With Williams Syndrome and Healthy Controls
NCT07537374 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Case-Control Observational Study of Peripheral Blood-Derived iPSC Models to Investigate Oligodendrocyte Lineage Development in Children With Williams Syndrome and Healthy Controls
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 1, 2026
- Completion date
- January 1, 2027
- Enrollment
- 6 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
induced pluripotent stem cell (ips cell), williams syndrome